UBS Group
XLABW icon

UBS Group’s Exascale Labs Holdings Inc. Warrant XLABW Stock Holding History

UBS Group’s Portfolio XLABW Stock Details XLABW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.47K Buy
+9,164
New +$2.74K ﹤0.01% 10249

Other funds holding XLABW

Context Capital Management
Context Capital Management Lajolla, California $4.89B AUM 1.86% 1-Year Est. Return
Wolverine Asset Management
Wolverine Asset Management Chicago, Illinois $14.9B AUM 3.61% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $33.5B AUM 25.57% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $755M AUM 21.42% 1-Year Est. Return

UBS Group's XLABW Position: Q3 2026 in Review

UBS Group opened a new position in Exascale Labs Holdings Inc. Warrant (XLABW) in Q3 2026: 9,164 shares worth $1.47K. The stake represents ﹤0.01% of the portfolio and ranks #10249 among its holdings.

5 funds tracked by Wall St. Rank hold XLABW as of Q3 2026.

  • UBS Group held 9,164 shares of Exascale Labs Holdings Inc. Warrant worth $1.47K as of Q3 2026.
  • Exascale Labs Holdings Inc. Warrant was a new UBS Group position in Q3 2026.
  • Exascale Labs Holdings Inc. Warrant made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #10249 holding.
  • 5 funds tracked by Wall St. Rank held Exascale Labs Holdings Inc. Warrant as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.